Tradestie Institutional Equity Comparison Engine
MRK vs UNOV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MRK Overall Edge
MRK Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Merck & Co., Inc. (MRK) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MRK trades at 16.1x Forward P/E with 35.2% operating margin (+4.7% YoY revenue) versus UNOV at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MRK sits in CONSOLIDATION (46th %ile IV; Dealer Gamma Walls on Pro) against UNOV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
MRK
MRK 16.1x vs UNOV N/M Fwd P/E
Growth & Margin Winner
MRK
Op Margin 35.2% vs N/A ยท YoY +4.7% vs N/A
Momentum & Technical Winner
MRK
1Y +55.5% vs +9.5% ยท 52W Pos 81% vs 84%
Options & Structure Winner
MRK
CONSOLIDATION (46th %ile IV) vs UNCLASSIFIED (N/A IV)
MRK
NYSE
Merck & Co., Inc.
Pharmaceutical Preparations
$144.46
-2.23% 1D
Market Cap
$364.3B
1M Return
-1.02%
1Y Return
+55.45%
Forward P/E
16.1x
Unified AI Score
56.6 / 100
HOLD
Tech 47.0
Fund 55.0
Flow 67.0
Mom 50.0
UNOV
Cboe BZX
Innovator U.S. Equity Ultra Buffer ETF - November
Pharmaceutical Preparations
$41.13
-0.95% 1D
Market Cap
N/A
1M Return
-0.97%
1Y Return
+9.53%
Forward P/E
N/M
Unified AI Score
58.7 / 100
HOLD
Tech 48.0
Fund 60.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MRK +55.45%
UNOV +9.53%
Spread: +45.92 pp (MRK Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MRK TTM Op. Margin: 35.2%
UNOV TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MRK vs UNOV. Trailing 12-month operating profitability (MRK 35.2% vs UNOV N/A) and valuation multiples (MRK 16.1x vs UNOV N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MRK | UNOV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $364.3B | N/A | Larger Scale | MRK |
| Trailing P/E Ratio Valuation | 147.8x | N/M | Lower Multiple | MRK |
| Forward P/E Ratio Valuation | 16.1x | N/M | Lower Multiple | MRK |
| Revenue Growth (YoY) Growth | +4.7% | N/A | Higher Growth | MRK |
| Operating Margin (TTM) Profitability | 35.2% | N/A | Higher Margin | MRK |
| Net Profit Margin Profitability | 3.6% | N/A | Higher Margin | MRK |
| Return on Equity (ROE) Capital Efficiency | 5.1% | N/A | Higher ROE | MRK |
| 52-Week Range Position Momentum | 81% ($91โ$157) | 84% ($37โ$42) | Stronger Trend | UNOV |
| Beta / 30D Volatility Risk Regime | 0.20ฮฒ ยท 32% Vol | 0.46ฮฒ ยท 11% Vol | Lower Realized Risk | UNOV |
| Unified Institutional Score Composite Signal | 56.6 / 100 (HOLD) | 58.7 / 100 (HOLD) | Higher Composite | UNOV |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MRK vs UNOV Buy Guide
MRK
CONSOLIDATION
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
46th %ile
IV Regime
Balanced (25thโ60th %ile)
UNOV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MRK nor UNOV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.